About
Corporate Overview
Founders
Management
Scientific Advisory Board
Board of Directors
Board of Advisors
Partnerships
Pleadings
Videos
ACP Testimonials
CEO Updates
News
Technology
Technology Overview
Manufacturing
Intellectual Property
Publications
Clinical Pipeline
ACP-01 Phase II Clinical Trial for CLI
CLI Phase II Trial Summary
Platform
Critical Limb Ischemia
Investors
Investor Overview
A Three Minute Summary
Public Filings
AGM Materials
News & Media
News / Press Releases
Contact
MENU ≡
About
Corporate Overview
Founders
Management
Scientific Advisory Board
Board of Directors
Board of Advisors
Partnerships
Pleadings
Videos
ACP Testimonials
CEO Updates
News
Technology
Technology Overview
Manufacturing
Intellectual Property
Publications
Clinical Pipeline
ACP-01 Phase II Clinical Trial for CLI
CLI Phase II Trial Summary
Platform
Critical Limb Ischemia
Investors
Investor Overview
A Three Minute Summary
Public Filings
AGM Materials
News & Media
News / Press Releases
Contact
News & Media
Hemostemix Announces CDN$4,400,000 Senior Secured Debt Financing and Plans to Undertake a Private Placement for up to CDN$8,000,000
April 10, 2017
For Full Press Release
Click Here
View All News & Media